amifostine anhydrous has been researched along with Respiratory Distress Syndrome in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, RB | 1 |
| Stockerl-Goldstein, KE | 1 |
| Klein, J | 1 |
| Murphy, J | 1 |
| Blume, KG | 1 |
| Dansey, R | 1 |
| Martinez, C | 1 |
| Matthes, S | 1 |
| Nieto, Y | 1 |
1 trial available for amifostine anhydrous and Respiratory Distress Syndrome
| Article | Year |
|---|---|
A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects.
Topics: Adult; Amifostine; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols | 2004 |